Literature DB >> 16472275

Drug-induced QT prolongation: an update.

Arthur J Moss.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16472275      PMCID： PMC6932541          DOI： 10.1111/j.1542-474X.2006.00086.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN： 1082-720X            Impact factor:   1.468


× No keyword cloud information.
  6 in total

1.  ISHNE guidelines for electrocardiographic evaluation of drug-related QT prolongation and other alterations in ventricular repolarization: task force summary. A report of the Task Force of the International Society for Holter and Noninvasive Electrocardiology (ISHNE), Committee on Ventricular Repolarization.

Authors:  A J Moss; W Zareba; J Benhorin; J P Couderc; H Kennedy; E Locati-Heilbron; P Maison-Blanche
Journal:  Ann Noninvasive Electrocardiol       Date:  2001-10       Impact factor: 1.468

2.  A structural basis for drug-induced long QT syndrome.

Authors:  J S Mitcheson; J Chen; M Lin; C Culberson; M C Sanguinetti
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

3.  Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel.

Authors:  Arthur J Moss; Wojciech Zareba; Elizabeth S Kaufman; Eric Gartman; Derick R Peterson; Jesaia Benhorin; Jeffrey A Towbin; Mark T Keating; Silvia G Priori; Peter J Schwartz; G Michael Vincent; Jennifer L Robinson; Mark L Andrews; Changyong Feng; W Jackson Hall; Aharon Medina; Li Zhang; Zhiqing Wang
Journal:  Circulation       Date:  2002-02-19       Impact factor: 29.690

Review 4.  Measurement of the QT interval and the risk associated with QTc interval prolongation: a review.

Authors:  A J Moss
Journal:  Am J Cardiol       Date:  1993-08-26       Impact factor: 2.778

5.  Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.

Authors:  D S Echt; P R Liebson; L B Mitchell; R W Peters; D Obias-Manno; A H Barker; D Arensberg; A Baker; L Friedman; H L Greene
Journal:  N Engl J Med       Date:  1991-03-21       Impact factor: 91.245

6.  Torsades de pointes occurring in association with terfenadine use.

Authors:  B P Monahan; C L Ferguson; E S Killeavy; B K Lloyd; J Troy; L R Cantilena
Journal:  JAMA       Date:  1990-12-05       Impact factor: 56.272
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.